Profile
Robert Gundel is the founder of Chatham Consulting Group, Inc. (founded in 2007).
He was the President, CEO & Non-Independent Director of ProMIS Neurosciences, Inc. from 2010 to 2015.
He held the position of Director-Pharmacology at Bayer Corp.
and Vice President-Pharmacology & Preclinical Research at Chiron Corp.
He was also the Chief Scientific Officer at Arius Research, Inc. in 2008 and Vice President-Research & Development at Elusys Therapeutics, Inc. in 2008.
In addition, he served as the Interim Chief Scientific & Technology Officer at Scorpius Holdings, Inc. in 2009 and Vice President-Scientific & Corporate Development at XOMA (US) LLC from 2005 to 2007.
Dr. Gundel holds an MBA from St. Mary's College of California and a doctorate from New York Medical College.
Former positions of Robert Gundel
| Companies | Position | End |
|---|---|---|
| PROMIS NEUROSCIENCES, INC. | Chief Executive Officer | 2015-06-28 |
| SCORPIUS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 2008-12-31 |
Elusys Therapeutics, Inc.
Elusys Therapeutics, Inc. BiotechnologyHealth Technology Develops immune-stimulatory and immune-derived therapies for the treatment of infectious diseases | Chief Tech/Sci/R&D Officer | 2008-10-31 |
Arius Research, Inc.
Arius Research, Inc. BiotechnologyHealth Technology Develops anti-cancer antibodies | Chief Tech/Sci/R&D Officer | 2007-12-31 |
XOMA (US) LLC
XOMA (US) LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical preparations | Corporate Officer/Principal | 2006-12-31 |
Training of Robert Gundel
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Bayer Corp.
Bayer Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical, healthcare & agricultural products | Health Technology |
Arius Research, Inc.
Arius Research, Inc. BiotechnologyHealth Technology Develops anti-cancer antibodies | Health Technology |
Elusys Therapeutics, Inc.
Elusys Therapeutics, Inc. BiotechnologyHealth Technology Develops immune-stimulatory and immune-derived therapies for the treatment of infectious diseases | Health Technology |
Scorpius Holdings, Inc.
Scorpius Holdings, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of therapies | Health Technology |
ProMIS Neurosciences, Inc.
ProMIS Neurosciences, Inc. BiotechnologyHealth Technology Discovers and develops precision medicine solutions for the treatment of neurodegenerative & misfolded protein diseases | Health Technology |
St. Mary's College of California
St. Mary's College of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York Medical College
New York Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
XOMA (US) LLC
XOMA (US) LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical preparations | Health Technology |
Chatham Consulting Group, Inc.
Chatham Consulting Group, Inc. Insurance Brokers/ServicesFinance Chatham Consulting Group, Inc. is a private company based in Armonk, NY. The company was founded by Robert Gundel. | Finance |
- Stock Market
- Insiders
- Robert Gundel
















